Most cited papers from Biomay (Austria)

Biomay (Austria)

What are the most cited papers from Biomay (Austria)?

The most cited paper from Biomay (Austria) is "Crystal Structure of a Hypoallergenic Isoform of the Major Birch Pollen Allergen Bet v 1 and its Likely Biological Function as a Plant Steroid Carrier" (Z. Marković-Housley, Massimo Degano, Doriano Lamba et al., 2002), with 302 citations. Next come "EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification" (196) and "MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine" (184).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 71 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Crystal Structure of a Hypoallergenic Isoform of the Major Birch Pollen Allergen Bet v 1 and its Likely Biological Function as a Plant Steroid Carrier Z. Marković-Housley, Massimo Degano, Doriano Lamba et al. · Journal of Molecular Biology	10 Dec 2002	302
2	EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification Ronald van Ree et al. · Allergy	4 Feb 2008	196
3	MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine Jean Bousquet et al. · Allergy Open access	24 Jan 2011	184
4	Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy Margarete Focke‐Tejkl, Milena Weber, Katarzyna Niespodziana et al. · Journal of Allergy and Clinical Immunology Open access	16 Nov 2014	142
5	Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy Petra Ursula Zieglmayer, Margarete Focke‐Tejkl, René Schmutz et al. · EBioMedicine Open access	23 Aug 2016	141
6	Are allergic multimorbidities and IgE polysensitization associated with the persistence or re‐occurrence of foetal type 2 signalling? The M e DALL hypothesis Jean Bousquet et al. · Allergy Open access	24 Apr 2015	118
7	Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32 Verena Niederberger et al. · Journal of Allergy and Clinical Immunology Open access	17 Jan 2018	116
8	Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens Merima Bublin, Marina Pfister, Christian Radauer et al. · Journal of Allergy and Clinical Immunology Open access	13 Jan 2010	109
9	Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy Laurian Zuidmeer et al. · International Archives of Allergy and Immunology Open access	2015	108
10	Recombinant allergens: What does the future hold? Rudolf Valenta, Katarzyna Niespodziana, Margit Focke-Tejkl et al. · Journal of Allergy and Clinical Immunology Open access	Apr 2011	85
11	Purification and structural stability of the peach allergens Pru p 1 and Pru p 3 Sonja Gaier, Justin T. Marsh, Christina Oberhuber et al. · Molecular Nutrition & Food Research	2 Apr 2008	81
12	Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy Tamar Kinaciyan, Birgit Nagl, Sandra Faustmann et al. · Journal of Allergy and Clinical Immunology	2 Sep 2017	77
13	Crystal Structure of the Major Celery Allergen Api g 1: Molecular Analysis of Cross-reactivity Tilman Schirmer, Karin Hoffimann-Sommergrube, Markus Susani et al. · Journal of Molecular Biology	12 Jul 2005	76
14	In vitro Analysis of Birch-Pollen-Associated Food Allergy by Use of Recombinant Allergens in the Basophil Activation Test S. M. Erdmann, Bernhardt Sachs, Alina D. Schmidt et al. · International Archives of Allergy and Immunology	2005	74
15	Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy Raphaela Freidl, Antonia Gstoettner, Ulrike Baranyi et al. · Journal of Allergy and Clinical Immunology Open access	19 Nov 2016	68
16	FAST: towards safe and effective subcutaneous immunotherapy of persistent life‐threatening food allergies Laurian Zuidmeer et al. · Clinical and Translational Allergy Open access	2012	67
17	Standardization of allergen products: 1. Detailed characterization of GMP‐produced recombinant Bet v 1.0101 as biological reference preparation Martin Himly, Emmanuel Nony, Henri Chabre et al. · Allergy	31 Jan 2009	66
18	Prevalence of IgE-Binding to Art v 1, Art v 4 and Amb a 1 in Mugwort-Allergic Patients Christina Oberhuber, Yan Ma, Nicole Wopfner et al. · International Archives of Allergy and Immunology	10 Sep 2007	64
19	Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy Christina Oberhuber, Sean Michael Bulley, Barbara K Ballmer-Weber et al. · Molecular Nutrition & Food Research	16 Oct 2008	62
20	Assessment of component-resolved in vitro diagnosis of celeriac allergy Kerstin Bauermeister, Barbara K Ballmer-Weber, Merima Bublin et al. · Journal of Allergy and Clinical Immunology	5 Oct 2009	60
21	Cloning and Molecular and Immunological Characterisation of Two New Food Allergens, Cap a 2 and Lyc e 1, Profilins from Bell Pepper (Capsicum annuum) and Tomato (Lycopersicon esculentum) Marika Willerroider, H. Fuchs, Barbara K Ballmer-Weber et al. · International Archives of Allergy and Immunology	2003	59
22	Comparison of natural and recombinant forms of the major fish allergen parvalbumin from cod and carp Yan Ma, Ulrike Griesmeier, Markus Susani et al. · Molecular Nutrition & Food Research	26 May 2008	56
23	Purification and characterisation of relevant natural and recombinant apple allergens Christina Oberhuber et al. · Molecular Nutrition & Food Research	6 Aug 2008	51
24	Recombinant house dust mite allergens Susanne Vrtala, Hans Gottlieb Huber, Wayne Robert Thomas · Methods Open access	31 Jul 2013	51
25	Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients Verena Niederberger, Katharina Marth, Julia Eckl‐Dorna et al. · Journal of Allergy and Clinical Immunology Open access	5 Jun 2015	47
26	A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy Ines Swoboda, Nadja Balic, Christoph Klug et al. · Journal of Allergy and Clinical Immunology Open access	25 Jun 2013	45
27	Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly Raffaela Campana, Susanne Vrtala, Bernhard Maderegger et al. · Journal of Allergy and Clinical Immunology Open access	17 Jul 2010	45
28	Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response Julia Eckl‐Dorna, Milena Weber, Victoria Stanek et al. · EBioMedicine Open access	28 Nov 2019	43
29	Rhinovirus Species–Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma Spyridon Megremis, Katarzyna Niespodziana, Clarissa R. Cabauatan et al. · American Journal of Respiratory and Critical Care Medicine Open access	22 Aug 2018	43
30	Amb a 1 isoforms: Unequal siblings with distinct immunological features Martin Wolf, Teresa E. Twaroch, Sara Huber et al. · Allergy Open access	2 May 2017	40
31	Responsiveness of the major birch allergen Bet v 1 scaffold to the gastric environment: Impact on structure and allergenic activity Ana I. Sancho, Andrea Wangorsch, Bettina M. Jensen et al. · Molecular Nutrition & Food Research	19 Jul 2011	40
32	Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments Raffaela Campana, Katharina Moritz, Katharina Marth et al. · Journal of Allergy and Clinical Immunology Open access	2 Nov 2015	40
33	Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer Raffaela Campana, Susanne Vrtala, Bernhard Maderegger et al. · Molecular Immunology Open access	26 Nov 2010	37
34	Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy Marija Geroldinger‐Simić, Tamar Kinaciyan, Birgit Nagl et al. · Journal of Allergy and Clinical Immunology	23 Aug 2012	35
35	Differences in the allergenicity of 6 different kiwifruit cultivars analyzed by prick-to-prick testing, open food challenges, and ELISA Thuy‐My Le, Philipp Fritsche, Merima Bublin et al. · Journal of Allergy and Clinical Immunology	21 Nov 2010	32
36	Allergen immunotherapy with the hypoallergenic B‐cell epitope‐based vaccine BM32 modifies IL‐10‐ and IL‐5‐secreting T cells Michèle Myriam Rauber, Christian Möbs, Raffaela Campana et al. · Allergy	22 Jul 2019	30
37	Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines Milena Weber, Katarzyna Niespodziana, Birgit Linhart et al. · Journal of Allergy and Clinical Immunology Open access	31 May 2017	29
38	Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy Christian Lupinek et al. · EBioMedicine Open access	13 Feb 2017	28
39	Structure of the major carrot allergen Dau c 1 Z. Marković-Housley, Arnaud Baslé, Sivaraman Padavattan et al. · Acta Crystallographica Section D Biological Crystallography	21 Oct 2009	28
40	Lab scale and medium scale production of recombinant allergens in Escherichia coli Michael Wallner, Petra Gruber, Christian Radauer et al. · Methods	7 Feb 2004	28
41	Resistance of parvalbumin to gastrointestinal digestion is required for profound and long‐lasting prophylactic oral tolerance Raphaela Freidl, Antonia Gstöttner, Ulrike Baranyi et al. · Allergy Open access	20 Jul 2019	27
42	Molecular Evolution of Hypoallergenic Hybrid Proteins for Vaccination against Grass Pollen Allergy Birgit Linhart, Margarete Focke‐Tejkl, Milena Weber et al. · The Journal of Immunology Open access	19 Mar 2015	27
43	Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard Martin Himly, Andreas Nandy, Helga Kahlert et al. · Allergy Open access	21 Dec 2015	24
44	Pru p 3 as a marker for symptom severity for patients with peach allergy in a birch pollen environment Sonja Gaier, Christina Oberhuber, Wolfgang Hemmer et al. · Journal of Allergy and Clinical Immunology Open access	15 Apr 2009	24
45	The CREATE Project: Development of Certified Reference Materials for Allergenic Products and Validation of Methods for Their Quantification Ronald van Ree et al. · Advanced topics in science and technology in China Book chapter	2012	23
46	Relationship between IgE Levels Specific for Ragweed Pollen Extract, Amb a 1 and Cross-Reactive Allergen Molecules Lauriana‐Eunice Zbîrcea, Maria Roxana Buzan, Manuela Grijincu et al. · International Journal of Molecular Sciences Open access	17 Feb 2023	22
47	Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen–associated apple allergy Dagmar Kollmann, Marija Geroldinger‐Simić, Tamar Kinaciyan et al. · Journal of Allergy and Clinical Immunology	28 Jun 2013	21
48	The Influence of Recombinant Production on the Immunologic Behavior of Birch Pollen Isoallergens Michael Wallner, Martin Himly, Angela Neubauer et al. · PLoS ONE Open access	23 Dec 2009	21
49	In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing Nikolaos Douladiris, Birgit Linhart, Ines Swoboda et al. · Journal of Allergy and Clinical Immunology Open access	5 Mar 2015	20
50	Complex IgE sensitization patterns in ragweed allergic patients: Implications for diagnosis and specific immunotherapy Maria Roxana Buzan, Lauriana‐Eunice Zbîrcea, Pia Gattinger et al. · Clinical and Translational Allergy Open access	Jul 2022	19

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.